Cubist Systematic Strategies’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$282K Buy
+3,800
New +$385K ﹤0.01% 2536
2025
Q1
Sell
-13,300
Closed -$2.47M 3152
2024
Q4
$2.47M Sell
13,300
-7,300
-35% -$1.42M 0.02% 1233
2024
Q3
$4.35M Buy
20,600
+2,100
+11% +$365K 0.03% 917
2024
Q2
$2.48M Buy
18,500
+14,200
+330% +$2.69M 0.02% 1194
2024
Q1
$924K Sell
4,300
-20,500
-83% -$4.02M 0.01% 2238
2023
Q4
$5.05M Buy
24,800
+6,300
+34% +$1.02M 0.03% 876
2023
Q3
$3.67M Buy
+18,500
New +$4.67M 0.03% 950

Other funds holding INSP

Cubist Systematic Strategies's INSP Position: Q3 2025 in Review

Cubist Systematic Strategies opened a new position in Inspire Medical Systems (INSP) in Q3 2025: 97,387 shares worth $7.23M. The stake represents 0.03% of the portfolio and ranks #744 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in INSP as recently as Q2 2024.

Cubist Systematic Strategies first reported a position in INSP in Q1 2019 and has held it in 21 quarters since. The position peaked at $30M in Q1 2023. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Cubist Systematic Strategies held 97,387 shares of Inspire Medical Systems worth $7.23M as of Q3 2025.
  • Inspire Medical Systems was a new Cubist Systematic Strategies position in Q3 2025.
  • Inspire Medical Systems made up 0.03% of Cubist Systematic Strategies's portfolio in Q3 2025, its #744 holding.
  • Cubist Systematic Strategies first reported a position in Inspire Medical Systems in Q1 2019 and has held it in 21 quarters since.
  • Cubist Systematic Strategies's Inspire Medical Systems position peaked at $30M in Q1 2023.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.